742067-24-9 Usage
Molecular Weight
291.37 g/mol The molecular weight is the mass of one mole of the compound, which is calculated by adding the atomic weights of all the atoms in the molecular formula.
Ester Class
2,8-Diazaspiro[4.5]decane-2-carboxylic acid, 8-acetyl-, 1,1-dimethylethyl ester belongs to the class of esters, which are compounds formed by the reaction of an acid and an alcohol.
Pharmaceutical Intermediate
2,8-Diazaspiro[4.5]decane-2-carboxylic acid, 8-acetyl-, 1,1-dimethylethyl ester is commonly used as a pharmaceutical intermediate in the synthesis of various drugs, meaning it is a key component in the production of active pharmaceutical ingredients.
Potential Medical Applications
2,8-Diazaspiro[4.5]decane-2-carboxylic acid, 8-acetyl-, 1,1-dimethylethyl ester has potential applications in the field of medicine, particularly in the development of treatments for neurological disorders and other related conditions.
Importance in Pharmaceutical Research and Development
The specific properties and applications of 2,8-Diazaspiro[4.5]decane-2-carboxylic acid, 8-acetyl-, 1,1-dimethylethyl ester make it a valuable and important chemical in pharmaceutical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 742067-24-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,4,2,0,6 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 742067-24:
(8*7)+(7*4)+(6*2)+(5*0)+(4*6)+(3*7)+(2*2)+(1*4)=149
149 % 10 = 9
So 742067-24-9 is a valid CAS Registry Number.
InChI:InChI=1/C15H26N2O3/c1-12(18)16-8-5-15(6-9-16)7-10-17(11-15)13(19)20-14(2,3)4/h5-11H2,1-4H3
742067-24-9Relevant academic research and scientific papers
SPIRO-SUBSTITUTED PYRROLOPYRIMIDINES
-
Page 40, (2008/06/13)
The invention provides compounds of formula (I) or a pharmaceutically acceptable salt or ester thereof formula (I) wherein the symbols have the meaning as defined in the description. Said compounds are inhibitors of cathepsin K and/or cathepsin S and are useful for the treatment of diseases and medical conditions in which cathepsin K and/or cathepsin S is implicated, e.g. various disorders including neuropathic pain, inflammation, rheumatoid arthritis, osteoarthritis, osteoporosis, multiple sclerosis and tumours.
2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF
-
Page/Page column 43, (2010/02/08)
The invention relates to pyrrolo pyrimidines of formula (I), wherein Y represents -(CH2)t-O- or -(CH2)r-S-, p is 1 or 2, r is 1, 2 or 3, t is 1, 2 or 3, or Y is -(CH2)j- or -CH=CH-, j is 1 or 2; p is 1 or 2, or Y is -(CH2)f-, f is 1 or 2, p is 1, and the further radicals and symbols have the meaning as defined herein; their preparation, their use as pharmaceuticals, pharmaceutical compositions containing them, the use of such a compound for the manufacture of a pharmaceutical preparation for the treatment of neuropathic pain and to a method for the treatment of such a disease in animals, especially in humans.
